Brechje de Gier

7PUBLICATIONS
22CO-AUTHORS
Respiratory diseasesSocio-economic developmentEpidemiological modellingPanel data analysisNutritional epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Oct 15, 2025
COVID-19 Vaccine Effectiveness in Patients With Hematologic Malignancies: A Nationwide Cohort Study.

Quincy Hofsink, Birgit I Lissenberg-Witte, Sabine Haggenburg

|Mar 27, 2025
Risk factors for invasive group A streptococcal infection in children aged 6 months to 5 years: a case-control study, the Netherlands, February-May 2023.

Elizabeth I Hazelhorst, Catharina E van Ewijk, Cornelia C H Wielders

|Mar 16, 2025
Comparison of two methods for the estimation of COVID-19 vaccine effectiveness of the autumnal booster within the VEBIS-EHR network in 2022/23.

Susana Monge, James Humphreys, Nathalie Nicolay

|Apr 24, 2024
Effectiveness of XBB.1.5 Monovalent COVID-19 Vaccines During a Period of XBB.1.5 Dominance in EU/EEA Countries, October to November 2023: A VEBIS-EHR Network Study.

Susana Monge, James Humphreys, Nathalie Nicolay

|Apr 24, 2023
Vaccine Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2 Delta and Omicron Infection and Infectiousness Within Households in the Netherlands Between July 2021 and August 2022.

Christina E Hoeve, Brechje de Gier, Anne J Huiberts

|Jun 26, 2019
Associations between common respiratory viruses and invasive group A streptococcal infection: A time-series analysis.

Brechje de Gier, Bart J M Vlaminckx, Sjoukje H S Woudt

Pageof 2

Frequent Collaborators

2 joint publications

Jesús Castilla

2 joint publications

Esther Kissling

1 joint publications

Merel N van Kassel

1 joint publications

Susana Monge